Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Discovery could lead to improved stem cell therapy
Whilst the human endometrium is known to harbour stem cells, this is the first time they have been obtained from the equine uterus.
Stem cells harvested from equine uterus for the first time

A new discovery could reduce pain and stress in horses undergoing stem cell therapy, according to a team of scientists who managed to harvest stem cells from the equine uterus for the first time.

Stem cells are used therapeutically in horses with tendon and joint injuries, but they are usually obtained surgically from bone marrow or fat tissue. However, stem cells can be taken from the uterus, without the need for surgical intervention, using small instruments inserted via the cervix.

Scientists from Vetmeduni Vienna collected uterine tissue samples from six mares. Suspected stem cells were separated from the endometrial epithelial cells and expanded in cell culture. Various molecular biology techniques were then used to identify potential stem cells.

The cells clearly expressed the same markers as bone marrow stem cells, according to the research team. They were also able to show that the endometrial stem cells differentiated into fat, bone, cartilage and muscle cell lines.

Whilst the human endometrium is known to harbour stem cells, this is the first time they have been obtained from the equine uterus.

“The endometrium provides a source of mesenchymal stem cells that can be easily accessed with little stress to the animals,” said senior researcher Christine Aurich.

“The cell culture results show that these cells can be of benefit not only in the treatment of uterine conditions, but that they can also replace the need for surgically obtained stem cells for therapeutic purposes in other tissue types.”

The full results have been published in the journal Stem Cell Research and Therapy.

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
Lords Committee opens Pet Parasite Medication inquiry

The House of Lords Environment and Climate Change Committee will launch its inquiry into Pet Parasite Medication (PPM) on Wednesday (3 June).

Focusing on treatments containing fipronil and imidacloprid, the inquiry will seek to understand distribution pathways and the impacts of PPM use and non-use on biodiversity and human health. It will also cover current regulation, monitoring, and the potential implications for pets and their owners.

The committee will hear evidence from environmental non-governmental organisations and research institutes. The public can follow the proceedings live on Parliament TV or in person in the Palace of Westminster.